Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Variable charge Y-linked 1B (VCY1B) is a small, highly positively charged nuclear protein encoded by the VCY1B gene, a member of the VCX/Y gene family found on both X and Y chromosomes[1][2][6]. These genes are expressed exclusively in male germ cells and share high sequence identity, though a repeated 30-bp unit typical in X-linked members occurs only once in Y-linked members[1][2][6]. While the precise biological function is unknown, the gene may be involved in spermatogenesis or play a role in sex ratio distortion[2]. There is currently no clear evidence that this protein is a conventional drug target, and there are no known drugs or well-defined mechanisms of action involving this molecule[2][6]. Key points: - VCY1B is not a conventional therapeutic target such as a receptor, enzyme, or transporter[2][6]. - The function of the protein remains unknown, though it may participate in male germ cell processes[2][6]. - It is associated with disorders related to male fertility, such as spermatogenic failure, but lacks a well-defined role in common disease pathways[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Variable charge Y-linked 1B (VCY1B).